OpenAlex
PricingAboutJobs
Log inGet started
Work

Phase 3 Trials of Solanezumab and Bapineuzumab for Alzheimer's Disease

HTML

Year: 2014
Type: letter
Source: New England Journal of Medicine
DOI: 10.1056/nejmc1402193
Author: Christoph Laske
Language: English

Topic: Alzheimer's disease research and treatments
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: solanezumab, bapineuzumab, Alzheimer's disease, amyloid-beta, preclinical Alzheimer's disease, A4 study, amyloid plaques, neurofibrillary tangles, treatment timing
SDG: Good health and well-being

Open Access status: closed

Funder: National Institute on Aging
Award: Alzheimer's Disease Cooperative Study
OpenAlex ID: W1268992491
Cites: 6
Cited by: 176
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms